Pediatrix Medical Group shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $8 to $14
Portfolio Pulse from Benzinga Newsdesk
Pediatrix Medical Group's stock is experiencing an upward trend following an upgrade by Jefferies from Hold to Buy, with a price target increase from $8 to $14.
September 26, 2024 | 4:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies has upgraded Pediatrix Medical Group from Hold to Buy, increasing the price target from $8 to $14, which has positively impacted the stock price.
The upgrade from Jefferies, a reputable financial services company, from Hold to Buy and the significant increase in the price target from $8 to $14 is likely to boost investor confidence and attract more buyers, leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100